F-18 fluorodeoxyglucose

also known as FDG

Investigated by: Boston Children's Hospital · Johns Hopkins University · National Institute for Biomedical Imaging and Bioengineering (NIBIB) · University of Florida

today NCT03107325 · Ph 4

20192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT03107325	Feb 2019 → Oct 2020	childhood neoplasm	Boston Children's Hospital	Withdrawn	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	F-18 fluorodeoxyglucose	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03107325 ↗
Known as	FDG	“F-18 fluorodeoxyglucose (FDG), a radiopharmaceutical commonly used in pediatric nuclear medicine” NCT03107325 ↗